Search This Blog

Friday, February 15, 2019

Globalization and disease

From Wikipedia, the free encyclopedia

Globalization, the flow of information, goods, capital, and people across political and geographic boundaries, allows infectious diseases to rapidly spread around the world, while also allowing the alleviation of factors such as hunger and poverty, which are key determinants of global health. The spread of diseases across wide geographic scales has increased through history. Early diseases that spread from Asia to Europe were bubonic plague, influenza of various types, and similar infectious diseases.

In the current era of globalization, the world is more interdependent than at any other time. Efficient and inexpensive transportation has left few places inaccessible, and increased global trade in agricultural products has brought more and more people into contact with animal diseases that have subsequently jumped species barriers (see zoonosis).

Globalization intensified during the Age of Exploration, but trading routes had long been established between Asia and Europe, along which diseases were also transmitted. An increase in travel has helped spread diseases to natives of lands who had not previously been exposed. When a native population is infected with a new disease, where they have not developed antibodies through generations of previous exposure, the new disease tends to run rampant within the population.

Etiology, the modern branch of science that deals with the causes of infectious disease, recognizes five major modes of disease transmission: airborne, waterborne, blood borne, by direct contact, and through vector (insects or other creatures that carry germs from one species to another). As humans began traveling over seas and across lands which were previously isolated, research suggests that diseases have been spread by all five transmission modes.

Travel patterns and globalization

The Age of Exploration generally refers to the period between the 15th and 17th centuries. During this time, technological advances in shipbuilding and navigation made it easier for nations to explore outside previous boundaries. Globalization has had many benefits, for example, new products to Europeans were discovered, such as tea, silk and sugar when Europeans developed new trade routes around Africa to India and the Spice Islands, Asia, and eventually running to the Americas

In addition to trading in goods, many nations began to trade in slavery. Trading in slaves was another way by which diseases were carried to new locations and peoples, for instance, from sub-Saharan Africa to the Caribbean and the Americas. During this time, different societies began to integrate, increasing the concentration of humans and animals in certain places, which led to the emergence of new diseases as some jumped in mutation from animals to humans. 

During this time sorcerers' and witch doctors' treatment of disease was often focused on magic and religion, and healing the entire body and soul, rather than focusing on a few symptoms like modern medicine. Early medicine often included the use of herbs and meditation. Based on archeological evidence, some prehistoric practitioners in both Europe and South America used trephining, making a hole in the skull to release illness. Severe diseases were often thought of as supernatural or magical. The result of the introduction of Eurasian diseases to the Americas was that many more native peoples were killed by disease and germs than by the colonists' use of guns or other weapons. Scholars estimate that over a period of four centuries, epidemic diseases wiped out as much as 90 percent of the American indigenous populations.

In Europe during the age of exploration, diseases such as smallpox, measles and tuberculosis (TB) had already been introduced centuries before through trade with Asia and Africa. People had developed some antibodies to these and other diseases from the Eurasian continent. When the Europeans traveled to new lands, they carried these diseases with them. (Note: Scholars believe TB was already endemic in the Americas.) When such diseases were introduced for the first time to new populations of humans, the effects on the native populations were widespread and deadly. The Columbian Exchange, referring to Christopher Columbus's first contact with the native peoples of the Caribbean, began the trade of animals, and plants, and unwittingly began an exchange of diseases.

It was not until the 1800s that humans began to recognize the existence and role of germs and microbes in relation to disease. Although many thinkers had ideas about germs, it was not until Louis Pasteur spread his theory about germs, and the need for washing hands and maintaining sanitation (particularly in medical practice), that anyone listened. Many people were quite skeptical, but on May 22, 1881 Pasteur persuasively demonstrated the validity of his germ theory of disease with an early example of vaccination. The anthrax vaccine was administered to 25 sheep while another 25 were used as a control. On May 31, 1881 all of the sheep were exposed to anthrax. While every sheep in the control group died, each of the vaccinated sheep survived. Pasteur’s experiment would become a milestone in disease prevention. His findings, in conjunction with other vaccines that followed, changed the way globalization affected the world.

Effects of globalization on disease in the modern world

Modern modes of transportation allow more people and products to travel around the world at a faster pace; they also open the airways to the transcontinental movement of infectious disease vectors. One example is the West Nile Virus. It is believed that this disease reached the United States via “mosquitoes that crossed the ocean by riding in airplane wheel wells and arrived in New York City in 1999.” With the use of air travel, people are able to go to foreign lands, contract a disease and not have any symptoms of illness until after they get home, and having exposed others to the disease along the way. 

As medicine has progressed, many vaccines and cures have been developed for some of the worst diseases (plague, syphilis, typhus, cholera, malaria) which people suffer. But, because the evolution of disease organisms is very rapid, even with vaccines, there is difficulty providing full immunity to many diseases. Finding vaccines at all for some diseases remains extremely difficult. Without vaccines, the global world remains vulnerable to infectious diseases. 

Evolution of disease presents a major threat in modern times. For example, the current "swine flu" or H1N1 virus is a new strain of an old form of flu, known for centuries as Asian flu based on its origin on that continent. From 1918–1920, a post-World War I global influenza epidemic killed an estimated 50–100 million people, including half a million in the United States alone. H1N1 is a virus that has evolved from and partially combined with portions of avian, swine, and human flu.

Globalization has increased the spread of infectious diseases from South to North, but also the risk of non-communicable diseases by transmission of culture and behavior from North to South. It is important to target and reduce the spread of infectious diseases in developing countries. However, addressing the risk factors of non-comunicable diseases and lifestyle risks in the South that cause disease, such as use or consumption of tobacco, alcohol, and unhealthy foods, is important as well.[9]

Specific diseases

Plague

Bubonic plague is a variant of the deadly flea-borne disease plague, which is caused by the enterobacteria Yersinia pestis, that devastated human populations beginning in the 14th century. Bubonic plague is primarily spread by fleas that lived on the black rat, an animal that originated in south Asia and spread to Europe by the 6th century. It became common to cities and villages, traveling by ship with explorers. A human would become infected after being bitten by an infected flea. The first sign of an infection of bubonic plague is swelling of the lymph nodes, and the formation of buboes. These buboes would first appear in the groin or armpit area, and would often ooze pus or blood. Eventually infected individuals would become covered with dark splotches caused by bleeding under the skin. The symptoms would be accompanied by a high fever, and within four to seven days of infection, more than half the victims would die. During the 14th and 15th century, humans did not know that a bacterium was the cause of plague, and efforts to slow the spread of disease were futile. 

The first recorded outbreak of plague occurred in China in the 1330s, a time when China was engaged in substantial trade with western Asia and Europe. The plague reached Europe in October 1347. It was thought to have been brought into Europe through the port of Messina, Sicily, by a fleet of Genoese trading ships from Kaffa, a seaport on the Crimean peninsula. When the ship left port in Kaffa, many of the inhabitants of the town were dying, and the crew was in a hurry to leave. By the time the fleet reached Messina, all the crew were either dead or dying; the rats that took passage with the ship slipped unnoticed to shore and carried the disease with them and their fleas.

Within Europe, the plague struck port cities first, then followed people along both sea and land trade routes. It raged through Italy into France and the British Isles. It was carried over the Alps into Switzerland, and eastward into Hungary and Russia. For a time during the 14th and 15th centuries, the plague would recede. Every ten to twenty years, it would return. Later epidemics, however, were never as widespread as the earlier outbreaks, when 60% of the population died.

The plague has never died out. From 1896–1918 the plague swept through India, taking the lives of over 12.5 million people. Between 1906 and 1914, the Plague Research Commission was created, and published supplements to the Journal of Hygiene.

Measles

Measles is a highly contagious airborne virus spread by contact with infected oral and nasal fluids. When a person with measles coughs or sneezes, he releases microscopic particles into the air. During the 4- to 12-day incubation period, an infected individual shows no symptoms, but as the disease progresses, the following symptoms appear: runny nose, cough, red eyes, extremely high fever and a rash. 

Measles is an endemic disease, meaning that it has been continually present in a community, and many people developed resistance. In populations that have not been exposed to measles, exposure to the new disease can be devastating. In 1529, a measles outbreak in Cuba killed two-thirds of the natives who had previously survived smallpox. Two years later measles was responsible for the deaths of half the indigenous population of Honduras, and ravaged Mexico, Central America, and the Inca civilization.

Historically, measles was very prevalent throughout the world, as it is highly contagious. According to the National Immunization Program, 90% of people were infected with measles by age 15, acquiring immunity to further outbreaks. Until a vaccine was developed in 1963, measles was considered to be deadlier than smallpox. Vaccination reduced the number of reported occurrences by 98%. Major epidemics have predominantly occurred in unvaccinated populations, particularly among nonwhite Hispanic and African American children under 5 years old. In 2000 a group of experts determined that measles was no longer endemic in the United States. The majority of cases that occur are among immigrants from other countries.

Typhus

Typhus is caused by rickettsia, which is transmitted to humans through lice. The main vector for typhus is the rat flea. Flea bites and infected flea feces in the respiratory tract are the two most common methods of transmission. In areas where rats are not common, typhus may also be transmitted through cat and opossum fleas. The incubation period of typhus is 7–14 days. The symptoms start with a fever, then headache, rash, and eventually stupor. Spontaneous recovery occurs in 80–90% of victims. 

The first outbreak of typhus was recorded in 1489. Historians believe that troops from the Balkans, hired by the Spanish army, brought it to Spain with them. By 1490 typhus traveled from the eastern Mediterranean into Spain and Italy, and by 1494, it had swept across Europe. From 1500–1914, more soldiers were killed by typhus than from all the combined military actions during that time. It was a disease associated with the crowded conditions of urban poverty and refugees as well. Finally, during World War I, governments instituted preventative delousing measures among the armed forces and other groups, and the disease began to decline. The creation of antibiotics has allowed disease to be controlled within two days of taking a 200 mg dose of tetracycline.

Syphilis

Syphilis is a sexually transmitted disease that causes open sores, delirium and rotting skin, and is characterized by genital ulcers. Syphilis can also do damage to the nervous system, brain and heart. The disease can be transmitted from mother to child.

The origins of syphilis are unknown, and some historians argue that it descended from a twenty-thousand-year-old African zoonosis. Other historians place its emergence in the New World, arguing that the crews of Columbus’s ships first brought the disease to Europe. The first recorded case of syphilis occurred in Naples in 1495, after King Charles VIII of France besieged the city of Naples, Italy. The soldiers, and the prostitutes who followed their camps, came from all corners of Europe. When they went home, they took the disease with them and spread it across the continent.

Smallpox

Smallpox is a highly contagious disease caused by the Variola virus. There are four variations of smallpox; variola major, variola minor, hemorrhagic, and malignant, with the most common being variola major and variola minor. Symptoms of the disease including hemorrhaging, blindness, back ache, vomiting, which generally occur shortly after the 12- to 17-day incubation period. The virus begins to attack skin cells, and eventually leads to an eruption of pimples that cover the whole body. As the disease progresses, the pimples fill up with pus or merge. This merging results in a sheet that can detach the bottom layer from the top layer of skin. The disease is easily transmitted through airborne pathways (coughing, sneezing, and breathing), as well as through contaminated bedding, clothing or other fabrics.

It is believed that smallpox first emerged over 3000 years ago, probably in India or Egypt. There have been numerous recorded devastating epidemics throughout the world, with high losses of life. 

Smallpox was a common disease in Eurasia in the 15th century, and was spread by explorers and invaders. After Columbus landed on the island of Hispaniola during his second voyage in 1493, local people started to die of a virulent infection. Before the smallpox epidemic started, more than one million indigenous people had lived on the island; afterward, only ten thousand had survived.

During the 16th century, Spanish soldiers introduced smallpox by contact with natives of the Aztec capital Tenochtitlan. A devastating epidemic broke out among the indigenous people, killing thousands.

In 1617, smallpox reached Massachusetts, probably brought by earlier explorers to Nova Scotia, Canada.” By 1638 the disease had broken out among people in Boston, Massachusetts. In 1721 people fled the city after an outbreak, but the residents spread the disease to others throughout the thirteen colonies. Smallpox broke out in six separate epidemics in the United States through 1968.

The smallpox vaccine was developed in 1798 by Edward Jenner. By 1979 the disease had been completely eradicated, with no new outbreaks. The WHO stopped providing vaccinations and by 1986, vaccination was no longer necessary to anyone in the world except in the event of future outbreak.

Leprosy

Leprosy, also known as Hansen’s Disease, is caused by a bacillus, Mycobacterium leprae. It is a chronic disease with an incubation period of up to five years. Symptoms often include irritation or erosion of the skin, and effects on the peripheral nerves, mucosa of the upper respiratory tract and eyes. The most common sign of leprosy are pale reddish spots on the skin that lack sensation.

Leprosy probably originated in India, more than four thousand years ago. It was prevalent in ancient societies in China, Egypt and India, and was transmitted throughout the world by various traveling groups, including Roman Legionnaires, Crusaders, Spanish conquistadors, Asian seafarers, European colonists, and Arab, African, and American slave traders. Some historians believe that Alexander the Great's troops brought leprosy from India to Europe during the 3rd century BC. With the help of the crusaders and other travelers, leprosy reached epidemic proportions by the 13th century. 

Once detected, leprosy can be cured using multi-drug therapy, composed of two or three antibiotics, depending on the type of leprosy. In 1991 the World Health Assembly began an attempt to eliminate leprosy. By 2005 116 of 122 countries were reported to be free of leprosy.

Malaria

On Nov. 6, 1880 Alphonse Laveran discovered that malaria (then called "Marsh Fever") was a protozoan parasite, and that mosquitoes carry and transmit malaria. Malaria is a protozoan infectious disease that is generally transmitted to humans by mosquitoes between dusk and dawn. The European variety, known as "vivax" after the Plasmodium vivax parasite, causes a relatively mild, yet chronically aggravating disease. The west African variety is caused by the sporozoan parasite, Plasmodium falciparum, and results in a severely debilitating and deadly disease.

Malaria was common in parts of the world where it has now disappeared, as the vast majority of Europe (disease of African descent are particularly diffused in the Empire romain) and North America . In some parts of England, mortality due to malaria was comparable to that of sub-Saharan Africa today. Although William Shakespeare was born at the beginning of a colder period called the "Little Ice Age", he knew enough ravages of this disease to include in eight parts. Plasmodium vivax lasted until 1958 in the polders of Belgium and the Netherlands. In the 1500s, it was the European settlers and their slaves who probably brought malaria on the American continent (we know that Columbus was suffering from this disease before his arrival in the new land). The Spanish Jesuit missionaries saw the Indians bordering on Lake Loxa Peru used the Cinchona bark powder to treat fevers. However, there is no reference to malaria in the medical literature of the Maya or Aztecs. The use of the bark of the "fever tree" was introduced into European medicine by Jesuit missionaries whose Barbabe Cobo who experimented in 1632 and also exports, so that the precious powder s' also called "Jesuit powder" . A study in 2012 of thousands of genetic markers for Plasmodium falciparum samples confirmed the African origin of the parasite in South America (Europeans themselves have been affected by this disease through Africa): it borrowed from the mid-sixteenth century and the mid-nineteenth the two main roads of the slave trade, the first leading to the north of South America (Colombia) by the Spanish, the second most leading south (Brazil) by Portugueses. 

Parts of the Third World are more affected by malaria than the rest of the world. For instance, many inhabitants of sub-Saharan Africa are affected by recurring attacks of malaria throughout their lives. In many areas of Africa, there is limited running water. The residents' use of wells and cisterns provides many sites for the breeding of mosquitoes and spread of the disease. Mosquitoes use areas of standing water like marshes, wetlands, and water drums to breed.

Tuberculosis

The bacterium that causes tuberculosis, Mycobacterium tuberculosis, is generally spread when an infected person coughs and another person inhales the bacteria. Once inhaled TB frequently grows in the lungs, but can spread to any part of the body. Although TB is highly contagious, in most cases the human body is able to fend off the bacteria. But, TB can remain dormant in the body for years, and become active unexpectedly. If and when the disease does become active in the body, it can multiply rapidly, causing the person to develop many symptoms including cough (sometimes with blood), night sweats, fever, chest pains, loss of appetite and loss of weight. This disease can occur in both adults and children and is especially common among those with weak or undeveloped immune systems.

Tuberculosis (TB) has been one of history’s greatest killers, taking the lives of over 3 million people annually. It has been called the "white plague". According to the WHO, approximately fifty percent of people infected with TB today live in Asia. It is the most prevalent, life-threatening infection among AIDS patients. It has increased in areas where HIV seroprevalence is high.

Air travel and the other methods of travel which have made global interaction easier, have increased the spread of TB across different societies. Luckily, the BCG vaccine was developed, which prevents TB meningitis and miliary TB in childhood. But, the vaccine does not provide substantial protection against the more virulent forms of TB found among adults. Most forms of TB can be treated with antibiotics to kill the bacteria. The two antibiotics most commonly used are rifampicin and isoniazid. There are dangers, however, of a rise of antibiotic-resistant TB. The TB treatment regimen is lengthy, and difficult for poor and disorganized people to complete, increasing resistance of bacteria. Antibiotic-resistant TB is also known as "multidrug-resistant tuberculosis." "Multidrug-resistant tuberculosis" is a pandemic that is on the rise. Patients with MDR-TB are mostly young adults who are not infected with HIV or have other existing illness. Due to the lack of health care infrastructure in underdeveloped countries, there is a debate as to whether treating MDR-TB will be cost effective or not. The reason is the high cost of "second-line" antituberculosis medications. It has been argued that the reason the cost of treating patients with MDR-TB is high is because there has been a shift in focus in the medical field, in particular the rise of AIDS, which is now the world's leading infectious cause of death. Nonetheless, it is still important to put in the effort to help and treat patients with "multidrug-resistant tuberculosis" in poor countries.

HIV/AIDS

HIV and AIDS are among the newest and deadliest diseases. According to the World Health Organization, it is unknown where the HIV virus originated, but it appeared to move from animals to humans. It may have been isolated within many groups throughout the world. It is believed that HIV arose from another, less harmful virus, that mutated and became more virulent. The first two AIDS/HIV cases were detected in 1981. As of 2013, an estimated 1.3 million persons in the United States were living with HIV or AIDS, almost 110,000 in the UK  and an estimated 35 million people worldwide are living with HIV”.

Despite efforts in numerous countries, awareness and prevention programs have not been effective enough to reduce the numbers of new HIV cases in many parts of the world, where it is associated with high mobility of men, poverty and sexual mores among certain populations. Uganda has had an effective program, however. Even in countries where the epidemic has a very high impact, such as Swaziland and South Africa, a large proportion of the population do not believe they are at risk of becoming infected. Even in countries such as the UK, there is no significant decline in certain at-risk communities. 2014 saw the greatest number of new diagnoses in gay men, the equivalent of nine being diagnosed a day.

Initially, HIV prevention methods focused primarily on preventing the sexual transmission of HIV through behavior change. The ABC Approach - "Abstinence, Be faithful, Use a Condom". However, by the mid-2000s, it became evident that effective HIV prevention requires more than that and that interventions need to take into account underlying socio-cultural, economic, political, legal and other contextual factors.

Ebola

The Ebola outbreak, which was the 26th outbreak since 1976, started in Guinea in March 2014. The WHO warned that the number of Ebola patients could rise to 20,000, and said that it used $489m (£294m) to contain Ebola within six to nine months. The outbreak was accelerating. Medecins sans Frontieres has just opened a new Ebola hospital in Monrovia, and after one week it is already a capacity of 120 patients. It said that the number of patients seeking treatment at its new Monrovia center was increasing faster than they could handle both in terms of the number of beds and the capacity of the staff, adding that it was struggling to cope with the caseload in the Liberian capital. Lindis Hurum, MSF's emergency coordinator in Monrovia, said that it was humanitarian emergency and they needed a full-scale humanitarian response. Brice de la Vinge, MSF director of operations, said that it was not until five months after the declaration of the Ebola outbreak that serious discussions started about international leadership and coordination, and said that it was not acceptable.

Leptospirosis

Leptospirosis, also known as field fever is an infection caused by Leptospira. Symptoms can range from none to mild such as headaches, muscle pains, and fevers; to severe with bleeding from the lungs or meningitis. Leptospira is transmitted by both wild and domestic animals, most commonly by rodents. It is often transmitted by animal urine or by water or soil containing animal urine coming into contact with breaks in the skin, eyes, mouth, or nose. The countries with the highest reported incidence are located in the Asia-Pacific region (Seychelles, India, Sri Lanka and Thailand) with incidence rates over 10 per 1000,000 people s well as in Latin America and the Caribbean (Trinidad and Tobago, Barbados, Jamaica, El Salvador, Uruguay, Cuba, Nicaragua and Costa Rica). However, the rise in global travel and eco-tourism  has led to dramatic changes in the epidemiology of leptospirosis, and travelers from around the world have become exposed to the threat of leptospirosis. Despite decreasing prevalence of leptospirosis in endemic regions, previously non-endemic countries are now reporting increasing numbers of cases due to recreational exposure  International travelers engaged in adventure sports are directly exposed to numerous infectious agents in the environment and now comprise a growing proportion of cases worldwide.

Non-communicable disease

Globalization can benefit people with non-communicable diseases such as heart problems or mental health problems. Global trade and rules set forth by the World Trade Organization can actually benefit the health of people by making their incomes higher, allowing them to afford better health care. While it has to be admitted making many non-communicable diseases more likely as well. Also the national income of a country, mostly obtained by trading on the global market, is important because it dictates how much a government spends on health care for its citizens. It also has to be acknowledged that an expansion in the definition of disease often accompanies development, so the net effect is not clearly beneficial due to this and other effects of increased affluence. Metabolic syndrome is one obvious example. Although poorer countries have not yet experienced this and are still suffering from diseases listed above.

Eradication of infectious diseases

From Wikipedia, the free encyclopedia

A child suffering from smallpox. In 1979, the World Health Organization announced the global eradication of smallpox. It is the only human disease to be eradicated worldwide.
 
Eradication is the reduction of an infectious disease's prevalence in the global host population to zero. It is sometimes confused with elimination, which describes either the reduction of an infectious disease's prevalence in a regional population to zero, or the reduction of the global prevalence to a negligible amount. Further confusion arises from the use of the term eradication to refer to the total removal of a given pathogen from an individual (also known as clearance of an infection), particularly in the context of HIV and certain other viruses where such cures are sought.

Selection of infectious diseases for eradication is based on rigorous criteria, as both biological and technical features determine whether a pathogenic organism is (at least potentially) eradicable. The targeted organism must not have a non-human reservoir (or, in the case of animal diseases, the infection reservoir must be an easily identifiable species, as in the case of rinderpest), and/or amplify in the environment. This implies that sufficient information on the life cycle and transmission dynamics is available at the time an eradication initiative is programmed. An efficient and practical intervention (such as a vaccine or antibiotic) must be available to interrupt transmission of the infectious agent. Studies of measles in the pre-vaccination era led to the concept of the critical community size, the size of the population below which a pathogen ceases to circulate. Use of vaccination programs before the introduction of an eradication campaign can reduce the susceptible population. The disease to be eradicated should be clearly identifiable, and an accurate diagnostic tool should exist. Economic considerations, as well as societal and political support and commitment, are other crucial factors that determine eradication feasibility.

Two infectious diseases have successfully been eradicated: smallpox and rinderpest. There are also four ongoing programs, targeting poliomyelitis, yaws, dracunculiasis, and malaria. Five more infectious diseases have been identified as of April 2008 as potentially eradicable with current technology by the Carter Center International Task Force for Disease Eradication—measles, mumps, rubella, lymphatic filariasis and cysticercosis.

Eradicated diseases

So far, two diseases have been successfully eradicated—one specifically affecting humans (smallpox), and one affecting a wide range of ruminants (rinderpest).

Smallpox

Boy with smallpox (1969). The last natural smallpox case was of Ali Maow Maalin, in Merca, Somalia, on 26 October 1977.
 
Smallpox was the first disease, and so far the only infectious disease of humans, to be eradicated by deliberate intervention. It became the first disease for which there was an effective vaccine in 1798 when Edward Jenner showed the protective effect of inoculation (vaccination) of humans with material from cowpox lesions.

Smallpox (variola) occurred in two clinical varieties: variola major, with a mortality rate of up to 40 percent, and variola minor, also known as alastrim, with a mortality rate less than one percent. The last naturally occurring case of Variola major was diagnosed in October 1975 in Bangladesh. The last naturally occurring case of smallpox (Variola minor) was diagnosed on 26 October 1977, on Ali Maow Maalin, in the Merca District, of Somalia. The source of this case was a known outbreak in the nearby district of Kurtuware. All 211 contacts were traced, revaccinated, and kept under surveillance.

After two years' detailed analysis of national records the global eradication of smallpox was certified by an international commission of smallpox clinicians and medical scientists on 9 December 1979, and endorsed by the General Assembly of the World Health Organization on 8 May 1980. However, there is an ongoing controversy regarding the continued storage of the smallpox virus by labs in the US and Russia, as any accidental or deliberate release could create a new epidemic for persons born after or in the late 1980s due to the cessation of vaccinations against the smallpox virus.

Rinderpest

During the 20th century, there were a series of campaigns to eradicate rinderpest, a viral disease which infected cattle and other ruminants and belonged to the same family as measles, primarily through the use of a live attenuated vaccine. The final, successful campaign was led by the Food and Agriculture Organization of the United Nations. On 14 October 2010, with no diagnoses for nine years, the Food and Agriculture Organization announced that the disease had been completely eradicated, making this the first (and so far the only) disease of livestock to have been eradicated by human undertakings.

Global eradication underway

Poliomyelitis (polio)

International wild poliovirus cases by year
Year Estimated Recorded
1975 49,293
1980 400,000 52,552
1985 38,637
1988 350,000 35,251
1990 23,484
1993 100,000 10,487
1995 7,035
2000 2,971
2005 1,998
2010 1,352
2011 650
2012 222
2013 385
2014 359
2015 74
2016 37
2017 22
2018 33

A dramatic reduction of the incidence of poliomyelitis in industrialized countries followed the development of a vaccine in the 1950s. In 1960, Czechoslovakia became the first country certified to have eliminated polio. 

In 1988, the World Health Organization (WHO), Rotary International, the United Nations Children's Fund (UNICEF), and the United States Centers for Disease Control and Prevention (CDC) passed the Global Polio Eradication Initiative. Its goal was to eradicate polio by the year 2000. The updated strategic plan for 2004–2008 expects to achieve global eradication by interrupting poliovirus transmission, using the strategies of routine immunization, supplementary immunization campaigns, and surveillance of possible outbreaks. The WHO estimates that global savings from eradication, due to forgone treatment and disability costs, could exceed one billion U.S. dollars per year.
The following world regions have been declared polio-free:
The lowest annual wild polio prevalence seen so far was in 2017, with only 22 reported cases, although there were more total reported cases (including circulated vaccine-derived cases) than in 2016, mainly due to reporting of circulated vaccine-derived cases in Syria, where it likely had already been circulating, but gone unreported, presumably due to the civil war. Only two or three countries remain in which poliovirus transmission may never have been interrupted: Pakistan, Afghanistan, and perhaps Nigeria. (There have been no cases caused by wild strains of poliovirus in Nigeria since August 2016, though cVDPV2 was detected in environmental samples in 2017.) Nigeria was removed from the WHO list of polio-endemic countries in September 2015 but added back in 2016, and India was removed in 2014 after no new cases were reported for one year.

On 20 September 2015, the World Health Organization announced that wild poliovirus type 2 had been eradicated worldwide, as it has not been seen since 1999. Wild poliovirus type 3 may also be eradicated as it has not been seen since 2012, leaving only wild poliovirus type 1 and circulating vaccine-derived polio circulating in a few isolated pockets, with all wild polio cases after August 2016 in Afghanistan and Pakistan.

Dracunculiasis

International Guinea worm cases by year
Year Reported cases Countries
1989 892,055 16
1995 129,852 19
2000 75,223 16
2005 10,674 12
2010 1,797 6
2011 1,060 4
2012 542 4
2013 148 5
2014 126 4
2015 22 4
2016 25 3
2017 30 2
2018 28 3

Dracunculiasis, also called Guinea worm disease, is a painful and disabling parasitic disease caused by a worm, Dracunculus medinensis. It is spread through consumption of drinking water infested with copepods hosting Dracunculus larvae. The Carter Center has led the effort to eradicate the disease, along with the CDC, the WHO, UNICEF, and the Bill and Melinda Gates Foundation.

Unlike diseases such as smallpox and polio, there is no vaccine or drug therapy for guinea worm. Eradication efforts have been based on making drinking water supplies safer (e.g. by provision of borehole wells, or through treating the water with larvicide), on containment of infection and on education for safe drinking water practices. These strategies have produced many successes: two decades of eradication efforts have reduced guinea worm's global incidence to 22 cases in 2015, after which cases rose to 25 cases in 2016, and 30 cases in 2017, but this is still down from an estimated 3.5 million in 1986. Success has been slower than was hoped—the original goal for eradication was 1995. The WHO has certified 180 countries free of the disease, and only three countries—South Sudan, Ethiopia, and Chad—reported cases of guinea worm in 2016, and only two—Ethiopia and Chad—in 2017. As of 2010, the WHO predicted it would be "a few years yet" before eradication is achieved, on the basis that it took 6–12 years for the countries that have so far eliminated guinea worm transmission to do so after reporting a similar number of cases to that reported by Sudan in 2009. The number of cases in 2016 (25) was less than 1% of the number in 2009, so real progress has been made towards this prediction. Nonetheless, the last 1% may be the hardest, and cases have increased from 2015 (22) to 2017 (30). The worm is able to infect dogs, domestic cats and baboons as well as humans, complicating eradication efforts.

Yaws

Yaws is a rarely fatal but highly disfiguring disease caused by the spiral-shaped bacterium (spirochete) Treponema pallidum pertenue, a close relative of the syphilis bacteria Treponema pallidum pallidum, spread through skin to skin contact with infectious lesions. The global prevalence of this disease and the other endemic treponematoses, bejel and pinta, was reduced by the Global Control of Treponematoses (TCP) program between 1952 and 1964 from about 50 million cases to about 2.5 million (a 95% reduction). However, following the cessation of this program these diseases remained at a low prevalence in parts of Asia, Africa and the Americas with sporadic outbreaks. According to a 2012 official WHO roadmap, the elimination should be achievable by 2020. Yaws is currently targeted by the South-East Asian Regional Office of the WHO for elimination from the remaining endemic countries in this region (India, Indonesia and East Timor) by 2010, and so far, this appears to have met with some success, since no cases have been seen in India since 2004. The discovery that oral antibiotic azithromycin can be used instead of the previous standard, injected penicillin, was tested on Lihir Island from 2013 to 2014; a single oral dose of the macrolide antibiotic reduced disease prevalence from 2.4% to 0.3% at 12 months. The campaign was in an early stage in 2013, still gathering data on disease incidence and planning initial large-scale treatment campaigns in Cameroon, Ghana, Indonesia, Papua New Guinea, the Solomon Islands, and Vanuatu.

Malaria

Malaria has been eliminated from most of Europe, North America, Australia, North Africa and the Caribbean, and parts of South America, Asia and Southern Africa. The WHO defines elimination as having no domestic transmission for the past three years. They also define an "elimination stage" when a country is on the verge of eliminating malaria, as being less than one case per 1000 people at risk per year. According to the 2011 WHO World Malaria Report, 28 countries are certified as having eliminated malaria. Eight countries appear to be malaria free but steps still need to be taken to ensure they do not re-establish transmission. Nine countries are in the elimination stage and eight the pre-elimination stage (fewer than 5 cases per 1000 people at risk per year).

In 1955 the WHO launched the Global Malaria Eradication Program (GMEP). Support waned, and the program was suspended in 1969. Since 2000, support for eradication has increased. According to the WHO's World Malaria Report 2015, the global mortality rate for malaria fell by 60% between 2000 and 2015. The WHO aims to achieve a further 90% reduction between 2015 and 2030. Bill Gates believes that global eradication is possible by 2040.

Regional elimination established or underway

Some diseases have already been eliminated from large regions of the world, and/or are currently being targeted for regional elimination. This is sometimes described as "eradication", although technically the term only applies when this is achieved on a global scale. Even after regional elimination is successful, interventions often need to continue to prevent a disease becoming re-established. Three of the diseases here listed (lymphatic filariasis, measles, and rubella) are among the diseases believed to be potentially eradicable by the International Task Force for Disease Eradication, and if successful, regional elimination programs may yet prove a stepping stone to later global eradication programs.This section does not cover elimination where it is used to mean control programs sufficiently tight to reduce the burden of an infectious disease or other health problem to a level where they may be deemed to have little impact on public health, such as the leprosy, neonatal tetanus, or obstetric fistula campaigns.

Hookworm

In North American countries, such as the United States, elimination of hookworm had been attained due to scientific advances (Despite the United States declaring that it had eliminated Hookworm decades ago, a 2017 study showed that it has re-emerged in poor rural black communities). The Rockefeller Foundation's hookworm campaign in the 1920s was supposed to focus on the eradication of hookworm infections for those living in Mexico and other rural areas. However, the campaign was politically influenced, causing it to be less successful, and regions such as Mexico still deal with these infections from parasitic worms. This use of health campaigns by political leaders for political and economic advantages has been termed the science-politics paradox.

Lymphatic filariasis

Lymphatic filariasis is an infection of the lymph system by mosquito-borne microfilarial worms which can cause elephantiasis. Studies have demonstrated that transmission of the infection can be broken when a single dose of combined oral medicines is consistently maintained annually for approximately seven years. The strategy for eliminating transmission of lymphatic filariasis is mass distribution of medicines that kill the microfilariae and stop transmission of the parasite by mosquitoes in endemic communities. In sub-Saharan Africa, albendazole is being used with ivermectin to treat the disease, whereas elsewhere in the world albendazole is used with diethylcarbamazine. Using a combination of treatments better reduces the number of microfilariae in blood. Avoiding mosquito bites, such as by using insecticide-treated mosquito bed nets, also reduces the transmission of lymphatic filariasis. In the Americas, more than 90% of the burden of lymphatic filariasis is on the island of Hispaniola (comprising Haiti and the Dominican Republic). An elimination effort to address this is currently under way alongside the malaria effort described above; the Dominican Republic expects to eliminate its seven remaining foci by 2010, but lymphatic filariasis is still endemic to 110 of 140 communes in Haiti.

As of October 2008, the efforts of the Global Programme to Eliminate LF are estimated to have already prevented 6.6 million new filariasis cases from developing in children, and to have stopped the progression of the disease in another 9.5 million people who have already contracted it. Overall, of 83 endemic countries, mass treatment has been rolled out in 48, and elimination of transmission reportedly achieved in 21.

Measles

Five out of six WHO regions have goals to eliminate measles, and at the 63rd World Health Assembly in May 2010, delegates agreed to move towards eventual eradication, although no specific global target date has yet been agreed. The Americas set a goal in 1994 to eliminate measles and rubella transmission by 2000, and successfully achieved regional measles elimination in 2002, although there have been occasional small outbreaks from imported cases since then. Europe had set a goal to eliminate measles transmission by 2010, but were hindered by the MMR vaccine controversy and by low uptake in certain groups, and despite achieving low levels by 2008, European countries have since experienced a small resurgence in cases. They have set a new target of 2015. The Eastern Mediterranean also had goals to eliminate measles by 2010 (later revised to 2015), the Western Pacific aims to eliminate the disease by 2012, and in 2009 the regional committee for Africa agreed a goal of measles elimination by 2020. As of May 2010, only the South-East Asian region has yet to set a target date for elimination of measles transmission.

In 2005, a global target was agreed for a 90% reduction in measles deaths by 2010 from the 757,000 deaths in 2000; estimates for 2008 show a 78% decline so far to 164,000 deaths. However, some have been pushing to attempt global eradication. This was updated at the 2010 World Health Assembly to a targeted 95% reduction in mortality by 2015, alongside specific vaccination and structural targets, and in a meeting in November 2010, the Strategic Advisory Group of Experts on Immunization "concluded that measles can and should be eradicated". A study of the costs of eradicating measles compared to the costs of maintaining indefinite control was commissioned in 2009 by the WHO and the Bill and Melinda Gates Foundation. In 2013, measles deaths globally were down to 145,700.

As of mid-2013, measles elimination in many areas is stalling. "This year, measles and rubella outbreaks are occurring in many areas of the world where people have no immunity to these viruses. The reasons people are unvaccinated range from lack of access to vaccines in areas of insecurity, to poor performing health systems, to vaccine refusals. We need to address each of these challenges if we’re going to meet global measles and rubella elimination goals," said Dr. Myrna Charles of the American Red Cross, as reported in a post in the Measles and Rubella Initiative's blog. A look at the WHO's epidemiological graph of measles over time from 2008-2013 show that, with little more of two years to go to 2015, measles cases in 2013 are moving in the wrong direction, with more cases this year than at the same point in 2012 or 2011.

During 2014 there were 23 outbreaks of measles in the United States and over 600 individual cases, which is the highest seen in decades. In 2015 the US has had one major outbreak of measles originating from an amusement park in California of a variant of the virus circulating in the Philippines in 2014. From this there have been 113 individual measles cases and one death (out of the total of 189 cases in the U.S. in 2015).

The WHO region of the Americas declared on 27 September 2016 it had eliminated measles. The last confirmed endemic case of measles in the Americas was in Brazil in July 2015. May 2017 saw a return of measles to the US after an outbreak in Minnesota among unvaccinated children. Another outbreak occurred in the state of New York between 2018 and 2019, causing over 200 confirmed measles cases in mostly ultra-Orthodox Jewish communities. Subsequent outbreaks occurred in New Jersey and Washington state with over 30 cases reported in the Pacific Northwest.

Rubella

The WHO region of the Americas declared on 29 April 2015 it had eliminated rubella and congenital rubella syndrome. The last confirmed endemic case of rubella in the Americas was in Argentina in February 2009. The WHO European region missed its elimination target of 2010 due to undervaccination in Central and Western Europe; it has set a new goal of 2015. The disease remains problematic in other regions; in Japan, there were 15,000 cases in 2013.

Onchocerciasis

Onchocerciasis (river blindness) is the world's second leading cause of infectious blindness. It is caused by the nematode Onchocerca volvulus, which is transmitted to people via the bite of a black fly. Elimination of this disease is under way in the region of the Americas, where this disease is endemic to Brazil, Colombia, Ecuador, Guatemala, Mexico and Venezuela. The principal tool being used is mass ivermectin treatment. If successful, the only remaining endemic locations would be in Africa and Yemen. In Africa, it is estimated that greater than 102 million people in 19 countries are at high risk of onchocerciasis infection, and in 2008, 56.7 million people in 15 of these countries received community-directed treatment with ivermectin. Since adopting such treatment measures in 1997, the African Programme for Onchocerciasis Control reports a reduction in the prevalence of onchocerciasis in the countries under its mandate from a pre-intervention level of 46.5% in 1995 to 28.5% in 2008. Some African countries, such as Uganda, are also attempting elimination and successful elimination was reported in 2009 from two endemic foci in Mali and Senegal.

On 29 July 2013, the Pan American Health Organization (PAHO) announced that after 16 years of efforts, Colombia had become the first country in the world to eliminate the parasitic disease onchocerciasis.

Bovine spongiform encephalopathy (BSE) and new variant Creutzfeldt–Jakob disease (vCJD)

Following an epidemic of vCJD in the UK in the 1990s, there have been campaigns to eliminate BSE in cattle across the EU and beyond which appear to have achieved large reductions in the number of cattle with this disease. Cases of vCJD have also fallen since then, for instance from an annual peak of 29 cases in 2000 to 5 cases in 2008 and zero in 2012. However, since then 2 cases have been reported in both 2013 and 2014: 2 in France; 1 in the United Kingdom; and 1 in the United States.

Following the ongoing eradication effort, only 7 cases of BSE were reported worldwide in 2013: 3 in the United Kingdom; 2 in France; 1 in Ireland; and 1 in Poland. This is the lowest number of cases since at least 1988. In 2015 there were at least 6 reported cases (3 were of the atypical H-type).

Syphilis

In 2015, Cuba became the first country in the world to eliminate mother-to-child syphilis. In 2017 the WHO certified that Antigua And Barbuda, Saint Kitts And Nevis and four British Overseas Territories—Anguilla, Bermuda, Cayman Islands, and Montserrat—have been certified that they have ended transmission of mother-to-child syphilis and HIV. Nevertheless eradication of syphilis by all transmission methods remains unresolved and many questions about the eradication effort remain to be answered.

African trypanosomiasis

Early planning by the WHO for the eradication of African trypanosomiasis, also known as sleeping sickness, is underway as the rate of reported cases continues to decline and passive treatment is continued. The WHO aims to completely eliminate transmission of the Trypanosoma brucei gambiense parasite by 2030, though it acknowledges that this goal "leaves no room for complacency."

Rabies

Rabies-free countries as of 2010

Because the rabies virus is almost always caught from animals, rabies eradication has focused on reducing the population of wild and stray animals, controls and compulsory quarantine on animals entering the country, and vaccination of pets and wild animals. Many island nations, including Iceland, Ireland, Japan, Malta, and the United Kingdom, managed to eliminate rabies during the twentieth century, and more recently much of continental Europe has been declared rabies-free.

Other eradicable diseases

As far as animal diseases are concerned, now that rinderpest has been stamped out, many experts believe peste des petits ruminants (PPR) is the next disease amenable to global eradication. Also known as goat plague or ovine rinderpest, PPR is a highly contagious viral disease of goats and sheep characterized by fever, painful sores in the mouth, tongue and feet, diarrhea, pneumonia and death, especially in young animals. It is caused by a virus of the genus Morbillivirus that is related to rinderpest, measles and canine distemper.

Desert greening

From Wikipedia, the free encyclopedia https://en.wikipedia.org/wiki/Desert_greening ...